Commonwealth Of Pennsylvania Public School Empls Retrmt Sys Ligand Pharmaceuticals Inc Transaction History

Commonwealth Of Pennsylvania Public School Empls Retrmt Sys

  • $16.4 Billion
  • Q1 2025

A detailed history of Commonwealth Of Pennsylvania Public School Empls Retrmt Sys transactions in Ligand Pharmaceuticals Inc stock. As of the latest transaction made, Commonwealth Of Pennsylvania Public School Empls Retrmt Sys holds 4,522 shares of LGND stock, worth $453,059. This represents 0.0% of its overall portfolio holdings.

Number of Shares
4,522
Previous 4,034 12.1%
Holding current value
$453,059
Previous $432,000 9.95%
% of portfolio
0.0%
Previous 0.0%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 13, 2025
BUY
$105.14 - $122.23 $51,308 - $59,648
488 Added 12.1%
4,522 $475,000
Q4 2024

Feb 11, 2025
BUY
$99.95 - $129.9 $12,893 - $16,757
129 Added 3.3%
4,034 $432,000
Q3 2024

Nov 07, 2024
BUY
$82.7 - $110.11 $21,998 - $29,289
266 Added 7.31%
3,905 $391,000
Q2 2024

Aug 12, 2024
BUY
$68.53 - $87.91 $6,853 - $8,791
100 Added 2.83%
3,639 $306,000
Q1 2024

May 08, 2024
BUY
$68.64 - $89.2 $137 - $178
2 Added 0.06%
3,539 $258,000
Q4 2023

Feb 09, 2024
SELL
$49.57 - $72.63 $365,330 - $535,283
-7,370 Reduced 67.57%
3,537 $252,000
Q3 2023

Nov 09, 2023
SELL
$58.86 - $72.67 $449,808 - $555,344
-7,642 Reduced 41.2%
10,907 $653,000
Q2 2023

Aug 09, 2023
BUY
$69.53 - $79.33 $108,188 - $123,437
1,556 Added 9.16%
18,549 $1.34 Million
Q1 2023

May 09, 2023
SELL
$65.67 - $77.08 $12,017 - $14,105
-183 Reduced 1.07%
16,993 $1.25 Million
Q4 2022

Feb 13, 2023
BUY
$61.72 - $96.74 $158,188 - $247,944
2,563 Added 17.54%
17,176 $1.15 Million
Q3 2022

Nov 14, 2022
SELL
$0.01 - $107.56 $7 - $81,422
-757 Reduced 4.93%
14,613 $1.26 Million
Q2 2022

Aug 15, 2022
BUY
$74.52 - $117.06 $71,762 - $112,728
963 Added 6.68%
15,370 $1.37 Million
Q1 2022

May 12, 2022
BUY
$94.99 - $151.56 $168,702 - $269,170
1,776 Added 14.06%
14,407 $1.62 Million
Q4 2021

Feb 11, 2022
SELL
$127.69 - $165.85 $1,787 - $2,321
-14 Reduced 0.11%
12,631 $1.95 Million
Q3 2021

Nov 10, 2021
BUY
$102.33 - $144.73 $726,338 - $1.03 Million
7,098 Added 127.96%
12,645 $1.76 Million
Q2 2021

Aug 12, 2021
BUY
$113.03 - $155.64 $565 - $778
5 Added 0.09%
5,547 $728,000
Q1 2021

May 12, 2021
BUY
$99.52 - $215.83 $17,117 - $37,122
172 Added 3.2%
5,542 $845,000
Q4 2020

Feb 12, 2021
BUY
$80.55 - $106.05 $17,479 - $23,012
217 Added 4.21%
5,370 $534,000
Q3 2020

Nov 12, 2020
BUY
$89.56 - $126.72 $157,356 - $222,647
1,757 Added 51.74%
5,153 $491,000
Q2 2020

Aug 11, 2020
SELL
$68.28 - $123.65 $33,252 - $60,217
-487 Reduced 12.54%
3,396 $380,000
Q1 2020

May 14, 2020
BUY
$63.37 - $107.88 $49,745 - $84,685
785 Added 25.34%
3,883 $282,000
Q4 2019

Feb 11, 2020
SELL
$96.94 - $113.59 $24,138 - $28,283
-249 Reduced 7.44%
3,098 $323,000
Q3 2019

Nov 14, 2019
SELL
$86.25 - $120.16 $9,228 - $12,857
-107 Reduced 3.1%
3,347 $333,000
Q2 2019

Aug 13, 2019
SELL
$107.38 - $129.34 $15,892 - $19,142
-148 Reduced 4.11%
3,454 $394,000
Q1 2019

May 07, 2019
SELL
$105.93 - $142.47 $13,559 - $18,236
-128 Reduced 3.43%
3,602 $453,000
Q4 2018

Feb 11, 2019
SELL
$128.36 - $272.13 $167,894 - $355,946
-1,308 Reduced 25.96%
3,730 $506,000
Q3 2018

Nov 08, 2018
BUY
$211.18 - $274.49 $111,503 - $144,930
528 Added 11.71%
5,038 $1.38 Million
Q2 2018

Aug 03, 2018
BUY
$150.77 - $207.98 $382,352 - $527,437
2,536 Added 128.47%
4,510 $934,000
Q1 2018

May 09, 2018
BUY
$138.63 - $182.62 $273,655 - $360,491
1,974 New
1,974 $326,000

Others Institutions Holding LGND

# of Institutions
280
Shares Held
19M
Call Options Held
9.5K
Put Options Held
8.1K
View Full List

About LIGAND PHARMACEUTICALS INC

LGND Quotes by TradingView
  • Ticker LGND
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 16,882,800
  • Market Cap $1.69B
  • Description
  • Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...
More about LGND
Track This Portfolio

Track Commonwealth Of Pennsylvania Public School Empls Retrmt Sys Portfolio

Follow Commonwealth Of Pennsylvania Public School Empls Retrmt Sys and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Commonwealth Of Pennsylvania Public School Empls Retrmt Sys, based on Form 13F filings with the SEC.

News

Stay updated on Commonwealth Of Pennsylvania Public School Empls Retrmt Sys with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email